DDS continues to create new method development techniques, such as small molecule biomarkers by LC-MS/MS and apply novel technologies to help answer your analytical challenges. DDS provide small molecule drugs and biomarker analysis for pharmacokinetic (PK) and pharmacodynamics (PD) determinations from discovery support through to regulated GLP preclinical and GCP clinical studies.
Flexible services include:
Manufacturer Drug Development Solutions
Be the first to review this product